Evidence map›Paper›PMID 29550416›Full record

ArticleThe Journal of investigative dermatology2018

Montagna Symposium 2017-Precision Dermatology: Next Generation Prevention, Diagnosis, and Treatment.

Jakub Tolar, Johann W Bauer, Daniel H Kaplan, Sancy A Leachman, John A McGrath, Amy S Paller, Kelly A Griffith-Bauer, Clara E Stemwedel, Molly F Kulesz-Martin

Abstract readConference Proceedings
PubMed Full text at PMC Publisher
In one paragraph

Article in The Journal of investigative dermatology, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Epidermolysis bullosa.Nature reviews. Disease primers · 2020
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors.

Jakub TolarDivision of Blood and Marrow Transplantation, Department of Pediatrics, University of Minnesota Medical School, Minneapolis, Minnesota, USA.
Johann W BauerEB House Austria, Research Program for Molecular Therapy of Genodermatoses, Department of Dermatology, University Hospital of the Paracelsus Medical University, Salzburg, Austria.
Daniel H KaplanDepartments of Dermatology and Immunology, University of Pittsburgh, Pittsburgh, Pennsylvania, USA.
Sancy A LeachmanDepartment of Dermatology, Oregon Health and Science University, Portland, Oregon, USA; Knight Cancer Institute, Oregon Health and Science University, Portland, Oregon, USA.
John A McGrathSt. Johns Institute of Dermatology, King's College London, Guys Campus, London, UK.
Amy S PallerDepartments of Dermatology and Pediatrics, Northwestern University Feinberg School of Medicine, Chicago, Illinois, USA.
Kelly A Griffith-BauerDepartment of Dermatology, University of California, San Francisco, School of Medicine, San Francisco, California, USA.
Clara E StemwedelDepartment of Dermatology, Oregon Health and Science University, Portland, Oregon, USA.
Molly F Kulesz-MartinDepartment of Dermatology, Oregon Health and Science University, Portland, Oregon, USA; Department of Cell, Developmental and Cancer Biology, Oregon Health and Science University, Portland, Oregon, USA. Electronic address: kuleszma@ohsu.edu.

Funding

Skin-targeted Cell Therapy for Recessive Dystrophic Epidermolysis BullosaR01AR063070 · NIAMS · UNIVERSITY OF MINNESOTA · PI Mark J Osborn, Jakub Tolar · 2013 to 2026
$4.5M
Montagna Symposium on the Biology of SkinR13AR009431 · NIAMS · UNIVERSITY OF COLORADO DENVER · PI SANCY ANN LEACHMAN · 1986 to 2026
$785k
NIAMS NIH HHS R01 AR063070NIAMS NIH HHS R13 AR009431
6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

Big DataBiomedical ResearchDermatologyGenomicsHumansPrecision MedicineSkinSkin DiseasesSocieties, Scientific

Identifiers

PMID29550416
PMCPMC5970097

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.